Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Celebrating TB day at the time of COVID-19.

Alagna R, Besozzi G, Codecasa LR, Gori A, Migliori GB, Raviglione M, Cirillo DM.

Eur Respir J. 2020 Apr 2. pii: 2000650. doi: 10.1183/13993003.00650-2020. [Epub ahead of print] No abstract available.

2.

Factors contributing to drug-resistant tuberculosis treatment outcome in five countries in the Eastern Europe and Central Asia region.

Auer C, Mazitov R, Makhmudov A, Pirmahmadzoda B, Skrahina A, Dobre A, Sécula F, Bosch-Capblanch X, Van den Boom M, Migliori GB, Mdivani N, Yassin MA.

Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1235.

3.

Adapting our Journal for the new decade (and the next 100 years).

Migliori GB, Leung CC, Blackbourn H.

Int J Tuberc Lung Dis. 2020 Mar 1;24(3):268-269. doi: 10.5588/ijtld.20.0062. No abstract available.

PMID:
32228754
4.

Shortened tuberculosis treatment regimens: what is new?

Silva DR, Mello FCQ, Migliori GB.

J Bras Pneumol. 2020 Mar 23;46(2):e20200009. doi: 10.36416/1806-3756/e20200009. eCollection 2020. English, Portuguese.

5.

Commemorating World TB Day 2020: "IT'S TIME" - It's time to End the Global TB Epidemic.

Tiberi S, Migliori GB, Muhwa Chakaya J, Kaesava T, Al Abri SS, Wejse C, Goletti D, Kapata N, Sotgiu G, Bomanji J, Zellweger JP, Hasan R, Irfan M, Ahmed I, Pshenichnaya N, Vasilieva I, Yeboah-Manu D, Alffenaar JW, Kim HY, Centis R, Cirillo DM, Alagna R, D'Ambrosio L, Cui X, Cao B, Maeurer M, Harries AD, Ippolito G, Raviglione M, Zumla A, Petersen E.

Int J Infect Dis. 2020 Mar;92S:S1-S4. doi: 10.1016/j.ijid.2020.03.001. Epub 2020 Mar 4. No abstract available.

6.

Tuberculosis series 2020.

Silva DR, Mello FCQ, Migliori GB.

J Bras Pneumol. 2020 Mar 2;46(2):e20200027. doi: 10.36416/1806-3756/e20200027. English, Portuguese. No abstract available.

7.

Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room.

Singla R, Raghu B, Gupta A, Caminero JA, Sethi P, Tayal D, Chakraborty A, Jain Y, Migliori GB.

Pulmonology. 2020 Feb 29. pii: S2531-0437(20)30026-X. doi: 10.1016/j.pulmoe.2020.02.002. [Epub ahead of print]

8.

Post tuberculosis treatment infectious complications.

Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, Zumla A, Visca D, Centis R, Tiberi S.

Int J Infect Dis. 2020 Mar;92S:S41-S45. doi: 10.1016/j.ijid.2020.02.032. Epub 2020 Feb 27.

9.

Non-tuberculous mycobacterial infections-A neglected and emerging problem.

Ahmed I, Tiberi S, Farooqi J, Jabeen K, Yeboah-Manu D, Migliori GB, Hasan R.

Int J Infect Dis. 2020 Mar;92S:S46-S50. doi: 10.1016/j.ijid.2020.02.022. Epub 2020 Feb 27.

10.

Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries.

Al Abri S, Kasaeva T, Migliori GB, Goletti D, Zenner D, Denholm J, Al Maani A, Cirillo DM, Schön T, Lillebæk T, Al-Jardani A, Go UY, Dias HM, Tiberi S, Al Yaquobi F, Khamis FA, Kurup P, Wilson M, Memish Z, Al Maqbali A, Akhtar M, Wejse C, Petersen E.

Int J Infect Dis. 2020 Mar;92S:S60-S68. doi: 10.1016/j.ijid.2020.02.042. Epub 2020 Feb 27.

11.

A postgraduate qualification in tuberculosis-Message in a bottle.

Tiberi S, Zumla A, Raviglione M, Lipman M, Kon OM, Griffiths C, Migliori GB.

Int J Infect Dis. 2020 Mar;92S:S100-S102. doi: 10.1016/j.ijid.2020.02.023. Epub 2020 Feb 27.

12.

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.

Migliori GB, Tiberi S, Zumla A, Petersen E, Chakaya JM, Wejse C, Muñoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ, Cirillo DM, Alagna R, Rendon A, Pontali E, Piubello A, Figueroa J, Ferlazzo G, García-Basteiro A, Centis R, Visca D, D'Ambrosio L, Sotgiu G; members of the Global Tuberculosis Network.

Int J Infect Dis. 2020 Mar;92S:S15-S25. doi: 10.1016/j.ijid.2020.01.042. Epub 2020 Feb 4.

13.

Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?

Alffenaar JC, Akkerman OW, Kim HY, Tiberi S, Migliori GB.

Int J Infect Dis. 2020 Mar;92S:S5-S9. doi: 10.1016/j.ijid.2020.01.041. Epub 2020 Jan 26.

14.

Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients.

Akkerman OW, Ter Beek L, Centis R, Maeurer M, Visca D, Muñoz-Torrico M, Tiberi S, Migliori GB.

Int J Infect Dis. 2020 Mar;92S:S10-S14. doi: 10.1016/j.ijid.2020.01.029. Epub 2020 Jan 23.

15.

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.

Campbell JR, Falzon D, Mirzayev F, Jaramillo E, Migliori GB, Mitnick CD, Ndjeka N, Menzies D.

Emerg Infect Dis. 2020 Mar;26(3). doi: 10.3201/eid2603.190997. Epub 2020 Mar 17.

16.

What is the best regimen to treat latent tuberculosis infection?

Tiberi S, Migliori GB.

Lancet Infect Dis. 2020 Mar;20(3):263-264. doi: 10.1016/S1473-3099(19)30627-9. Epub 2019 Dec 19. No abstract available.

PMID:
31866329
17.

Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis.

Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, Brode S, Campbell JR, Casas EC, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, Lange C, Li PZ, Makhmudova M, Maug AKJ, Menzies D, Migliori GB, Miller A, Myrzaliev B, Ndjeka N, Noeske J, Parpieva N, Piubello A, Schwoebel V, Sikhondze W, Singla R, Souleymane MB, Trébucq A, Van Deun A, Viney K, Weyer K, Zhang BJ, Ahmad Khan F.

Eur Respir J. 2020 Mar 20;55(3). pii: 1901467. doi: 10.1183/13993003.01467-2019. Print 2020 Mar.

PMID:
31862767
18.

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST. Erratum in: Am J Respir Crit Care Med. 2020 Feb 15;201(4):500-501.

19.

Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?

Alffenaar JC, Akkerman OW, Tiberi S, Sotgiu G, Migliori GB; Global Tuberculosis Network Bedaquiline study group.

Eur Respir J. 2020 Feb 12;55(2). pii: 1901908. doi: 10.1183/13993003.01908-2019. Print 2020 Feb. No abstract available.

PMID:
31699843
20.

European guidance on drug-resistant tuberculosis in children and adolescents.

Gröschel MI, Seddon JA, Prabowo SA, Migliori GB, Graham SM, van den Boom M, Dara M.

Lancet Child Adolesc Health. 2020 Jan;4(1):9-11. doi: 10.1016/S2352-4642(19)30332-3. Epub 2019 Oct 30. No abstract available.

PMID:
31676193
21.

Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and Treatment.

Tiberi S, Zumla A, Migliori GB.

Infect Dis Clin North Am. 2019 Dec;33(4):1063-1085. doi: 10.1016/j.idc.2019.09.002. Review.

PMID:
31668191
22.

TB consilia and quality of tuberculosis management.

Pontali E, Tadolini M, Migliori GB.

Int J Tuberc Lung Dis. 2019 Oct 1;23(10):1048-1049. doi: 10.5588/ijtld.19.0423. No abstract available.

PMID:
31627767
23.

Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.

Di Bella S, Siroka A, Antonello RM, Zignol M, Maschio M, Tominz R, Cirillo D, Migliori GB, Confalonieri M, Raviglione M, Luzzati R.

Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1024-1028. doi: 10.5588/ijtld.19.0060.

PMID:
31615611
24.

The future of drug-resistant tuberculosis treatment: learning from the past and the 2019 World Health Organization consolidated guidelines.

Caminero JA, García-Basteiro AL, Rendon A, Piubello A, Pontali E, Migliori GB.

Eur Respir J. 2019 Oct 10;54(4). pii: 1901272. doi: 10.1183/13993003.01272-2019. Print 2019 Oct. No abstract available.

PMID:
31601719
25.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Borisov S, Danila E, Maryandyshev A, Dalcolmo M, Miliauskas S, Kuksa L, Manga S, Skrahina A, Diktanas S, Codecasa LR, Aleksa A, Bruchfeld J, Koleva A, Piubello A, Udwadia ZF, Akkerman OW, Belilovski E, Bernal E, Boeree MJ, Cadiñanos Loidi J, Cai Q, Cebrian Gallardo JJ, Dara M, Davidavičienė E, Forsman LD, De Los Rios J, Denholm J, Drakšienė J, Duarte R, Elamin SE, Escobar Salinas N, Ferrarese M, Filippov A, Garcia A, García-García JM, Gaudiesiute I, Gavazova B, Gayoso R, Gomez Rosso R, Gruslys V, Gualano G, Hoefsloot W, Jonsson J, Khimova E, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Marchese V, Martínez Robles E, Matteelli A, Mazza-Stalder J, Moschos C, Muñoz-Torrico M, Mustafa Hamdan H, Nakčerienė B, Nicod L, Nieto Marcos M, Palmero DJ, Palmieri F, Papavasileiou A, Payen MC, Pontarelli A, Quirós S, Rendon A, Saderi L, Šmite A, Solovic I, Souleymane MB, Tadolini M, van den Boom M, Vescovo M, Viggiani P, Yedilbayev A, Zablockis R, Zhurkin D, Zignol M, Visca D, Spanevello A, Caminero JA, Alffenaar JW, Tiberi S, Centis R, D'Ambrosio L, Pontali E, Sotgiu G, Migliori GB.

Eur Respir J. 2019 Dec 19;54(6). pii: 1901522. doi: 10.1183/13993003.01522-2019. Print 2019 Dec.

PMID:
31601711
26.

Integrating pharmacokinetics and pharmacodynamics in operational research to End TB.

Alffenaar JC, Gumbo T, Dooley KE, Peloquin CA, McIlleron H, Zagorski A, Cirillo DM, Heysell SK, Silva DR, Migliori GB.

Clin Infect Dis. 2019 Sep 27. pii: ciz942. doi: 10.1093/cid/ciz942. [Epub ahead of print]

PMID:
31560376
27.

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group.

Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Review.

PMID:
31486393
28.

Multidrug-resistant tuberculosis - Authors' reply.

Menzies D, Benedetti A, Migliori GB, Nahid P, Seaworth B.

Lancet. 2019 Jul 27;394(10195):299-300. doi: 10.1016/S0140-6736(19)30692-0. No abstract available.

PMID:
31354139
29.

Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis.

Zampogna E, Centis R, Negri S, Fiore E, Cherubino F, Pignatti P, Heffler E, Canonica GW, Sotgiu G, Saderi L, Migliori GB, Spanevello A, Visca D.

J Asthma. 2019 Aug 13:1-7. doi: 10.1080/02770903.2019.1646271. [Epub ahead of print]

PMID:
31317799
30.

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives.

Pontali E, Raviglione MC, Migliori GB; and the writing group members of the Global TB Network Clinical Trials Committee.

Eur Respir Rev. 2019 May 29;28(152). pii: 190035. doi: 10.1183/16000617.0035-2019. Print 2019 Jun 30. Review.

31.

Effectiveness of interventions for reducing TB incidence in countries with low TB incidence: a systematic review of reviews.

Collin SM, Wurie F, Muzyamba MC, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, Zenner D.

Eur Respir Rev. 2019 May 29;28(152). pii: 180107. doi: 10.1183/16000617.0107-2018. Print 2019 Jun 30.

32.

Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients.

Walker IF, Shi O, Hicks JP, Elsey H, Wei X, Menzies D, Lan Z, Falzon D, Migliori GB, Pérez-Guzmán C, Vargas MH, García-García L, Sifuentes Osornio J, Ponce-De-León A, van der Walt M, Newell JN.

Eur Respir J. 2019 Jul 11;54(1). pii: 1800353. doi: 10.1183/13993003.00353-2018. Print 2019 Jul.

PMID:
31073080
33.

Tuberculosis series 2019.

Silva DR, Migliori GB, Mello FCQ.

J Bras Pneumol. 2019 Apr 25;45(2):e20190064. doi: 10.1590/1806-3713/e20190064. English, Portuguese. No abstract available.

34.

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?

Velizarova S, Gabrovska N, Spasova A, Marais B, Harausz EP, Tiberi S, Migliori GB, Manissero D.

J Bras Pneumol. 2019 Apr 25;45(2):e20190043. doi: 10.1590/1806-3713/e20190043. English, Portuguese. No abstract available.

35.

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis.

Migliori GB, Centis R, D'Ambrosio L, Silva DR, Rendon A.

J Bras Pneumol. 2019 Apr 25;45(2):e20180420. doi: 10.1590/1806-3713/e20180420. English, Portuguese.

36.

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.

Tiberi S, Torrico MM, Rahman A, Krutikov M, Visca D, Silva DR, Kunst H, Migliori GB.

J Bras Pneumol. 2019 Apr 25;45(2):e20180324. doi: 10.1590/1806-3713/e20180324. Review. English, Portuguese.

37.

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe.

Migliori GB, Nardell E, Yedilbayev A, D'Ambrosio L, Centis R, Tadolini M, van den Boom M, Ehsani S, Sotgiu G, Dara M.

Eur Respir J. 2019 Jun 5;53(6). pii: 1900391. doi: 10.1183/13993003.00391-2019. Print 2019 Jun.

PMID:
31023852
38.

Recent evidence on delamanid use for rifampicin-resistant tuberculosis.

Pontali E, Centis R, D'Ambrosio L, Toscanini F, Migliori GB.

J Thorac Dis. 2019 Mar;11(Suppl 3):S457-S460. doi: 10.21037/jtd.2018.11.26. No abstract available.

39.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

40.

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae.

Visca D, Zampogna E, Sotgiu G, Centis R, Saderi L, D'Ambrosio L, Pegoraro V, Pignatti P, Muňoz-Torrico M, Migliori GB, Spanevello A.

Eur Respir J. 2019 Mar 14;53(3). pii: 1802184. doi: 10.1183/13993003.02184-2018. Print 2019 Mar. No abstract available.

PMID:
30872556
41.

Prioritising children and adolescents in the tuberculosis response of the WHO European Region.

Gröschel MI, van den Boom M, Migliori GB, Dara M.

Eur Respir Rev. 2019 Mar 14;28(151). pii: 180106. doi: 10.1183/16000617.0106-2018. Print 2019 Mar 31. Review.

42.

Another aetiology for tuberculosis-beyond the Mycobacterium.

Santos AP, Migliori GB.

Int J Tuberc Lung Dis. 2019 Mar 1;23(3):277. doi: 10.5588/ijtld.19.0076. No abstract available.

PMID:
30871656
43.

Launching the Global TB Network.

Rendon A, Silva DR, Esposito S, Sotgiu G, Migliori GB, Chakaya JM.

Int J Tuberc Lung Dis. 2019 Feb 1;23(2):123-124. doi: 10.5588/ijtld.18.0648. No abstract available.

PMID:
30808446
44.

Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA.

Nasiri MJ, Pormohammad A, Goudarzi H, Mardani M, Zamani S, Migliori GB, Sotgiu G.

Infection. 2019 Jun;47(3):353-361. doi: 10.1007/s15010-019-01285-7. Epub 2019 Feb 25.

PMID:
30805899
45.

World Tuberculosis Day March 24th 2019 Theme: "It's TIME" - International Journal of Infectious Diseases Tuberculosis Theme Series.

Petersen E, Rao M, Ippolito G, Gualano G, Chakaya J, Ntoumi F, Moore D, Allen R, Gaskell K, Öhd JN, Hergens MP, Krishnamoorthy S, Ugarte-Gil C, Kirwan DE, Honeyborne I, McHugh TD, Köser CU, Kranzer K, Tiberi S, Migliori GB, Mao Q, Yang Y, Oliveira SP, Cardoso RF, Detjen A, Marais B, de Gijsel D, von Reyn CF, Goscé L, Abubakar I, Maeurer M, Zumla A.

Int J Infect Dis. 2019 Mar;80S:S1-S5. doi: 10.1016/j.ijid.2019.02.024. Epub 2019 Feb 23. No abstract available.

46.

Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.

Tiberi S, Pontali E, Tadolini M, D'Ambrosio L, Migliori GB.

Int J Infect Dis. 2019 Mar;80S:S68-S72. doi: 10.1016/j.ijid.2019.01.040. Epub 2019 Jan 25.

47.

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.

Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, Mandelbaum M, Matteelli A, Migliori GB, Oordt-Speets A, Solovic I, Vašáková M, Verver S, de Vlas SJ, Vonk Noordegraaf-Schouten MJM, de Vries G, Zenner D, van der Werf MJ.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802077. doi: 10.1183/13993003.02077-2018. Print 2019 Jan. No abstract available.

PMID:
30655449
48.

Delamanid: does it have a role in tuberculosis treatment?

Centis R, Sotgiu G, Migliori GB.

Lancet Respir Med. 2019 Mar;7(3):193-195. doi: 10.1016/S2213-2600(18)30455-7. Epub 2019 Jan 7. No abstract available.

PMID:
30630779
49.

ERS syllabus for postgraduate training in respiratory infections: a guide for comprehensive training.

Aliberti S, Farr A, Tabin N, Blasi F, Torres A, Woodhead M, Migliori GB, Sotgiu G, Dimopoulos G, Chalmers JD, Ringshausen FC, Loebinger MR, Read R, Rohde G.

Breathe (Sheff). 2018 Dec;14(4):269-275. doi: 10.1183/20734735.026218.

50.

The European Respiratory Society's 10 Principles for Lung Health.

Horváth I, Barry M, Brusselle G, Burghuber OC, Bush A, Robalo Cordeiro C, Gaga M, Gratziou C, Saraiva I, Stolz D, Troosters T, Welte T, Migliori GB, Joos G.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801373. doi: 10.1183/13993003.01373-2018. Print 2018 Nov. No abstract available.

PMID:
30498051

Supplemental Content

Loading ...
Support Center